University Chemistry ›› 2019, Vol. 34 ›› Issue (8): 47-50.doi: 10.3866/PKU.DXHX201905013

Special Issue:

Previous Articles     Next Articles

Self-Recommendation Letter of Baby Ruthenium: I Am an Anticancer Warrior

Wen MA,Weiguo JIA*()   

  • Received:2019-05-06 Accepted:2019-05-27 Published:2019-07-15
  • Contact: Weiguo JIA E-mail:wgjiasy@ahnu.edu.cn
  • Supported by:
    国家自然科学基金(21102004)

Abstract:

Using the anthropomorphic approach, this article introduces the discovery history of ruthenium elements in the first person role, and focuses on the ruthenium complexes as important therapeutic agents for cancer treatment. We have focused our attention on KP1019 incorporating ruthenium ions complexes which have been already used in clinical or have been advanced to clinical trials as anticancer agents. Moreover, the half-sandwich ruthenium and ruthenium polypyridine complexes drugs are also reviewed.

Key words: Ruthenium, Complex, Anticancer